Applied DNA Promotes Judy Murrah to COO
January 20th, 2021
Applied DNA Promotes Judy Murrah to COO
January 20th, 2021
Linea™ COVID-19 Assay Kit: Detection of Multiple SARS-CoV-2 Variants
January 19th, 2021
Business Update on COVID-19 Diagnostics and Testing
January 15th, 2021
Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 13th, 2021
Pricing of $15M Registered Direct Offering
January 11th, 2021
Assay Kit Can Detect Gene Mutation Found in SARS-CoV-2 U.K. Variant B.1.1.7
January 8th, 2021
APDN to Participate in H.C. Wainwright BIOCONNECT 2021 Conference
January 5th, 2021
Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
January 4th, 2021
APDN, CLEARED4 Partner on COVID-19 Testing Program
December 29th, 2020

Our new ticker symbol is ‘BNBX’. Learn more here.